ISA, Pharmaceuticals

ISA Pharmaceuticals and Cancer Focus Fund United Kingdom United States of America Netherlands

04.01.2023 - 13:03:22

ISA Pharmaceuticals and Cancer Focus Fund Announce $5 Million Investment to Support First-in-Human Trial of ISA's Novel Immunotherapy ISA103 in Uveal Melanoma

@ prnewswire.co.uk